Whereas some tumors such as gliomas exclusively express CD44s, other neoplasms including gastrointestinal cancer, bladder cancer, uterine cervical cancer, breast cancer, and HNSCC also express CD44 variants. This evidence concerns the gene CD44 and head and neck squamous cell carcinoma.